HIV testing pre- and post-COVID-19 pandemic among persons who inject drugs – National HIV Behavioral Surveillance, 19 cities, 2018 and 2022
Abstract
HIV testing decreased during the COVID-19 pandemic among persons who inject drugs (PWID), though it is unclear how these changes in HIV testing affected different sub-groups of PWID. We estimated the change in past-year HIV testing between 2018 and 2022 overall and by sociodemographic and health care characteristics among PWID. Past-year HIV testing significantly decreased between 2018 and 2022 overall and across most sub-groups of PWID, including PWID accessing and not accessing medical and harm reduction services. Integrating HIV testing across medical and harm reduction services accessed by PWID and expanding community-based HIV testing might increase HIV testing among PWID.
Full citation:
Hershow RB, Broz D, Faucher L, Feelemyer J, Chapin-Bardales J, Natl HIV Behav Surveillance Study Grp (2025). HIV testing pre- and post-COVID-19 pandemic among persons who inject drugs – National HIV Behavioral Surveillance, 19 cities, 2018 and 2022
AIDS and Behavior [Epub 2025 Mar 10]. doi: 10.1007/s10461-025-04672-4.